Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases

Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases

Chronic hepatobiliary damage progressively leads to fibrosis, which may evolve into cirrhosis and/or hepatocellular carcinoma. The fight against the increasing incidence of liver-related morbidity and mortality is challenged by a lack of clinically validated early-stage biomarkers and the limited av...

Full description

Saved in:
Bibliographic Details
Main Authors: Marilena Durazzo, Arianna Ferro, Victor Manuel Navarro-Tableros, Andrea Gaido, Paolo Fornengo, Fiorella Altruda, Renato Romagnoli, Søren K. Moestrup, Pier Luigi Calvo, Sharmila Fagoonee
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Biomolecules
Subjects:
liver fibrosis
inflammation
therapeutic interventions
nucleic acid-based therapeutics
stem cells
extracellular vesicles
Online Access:https://www.mdpi.com/2218-273X/15/1/121
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items